Document Type
Patent
Publication Date
September 2010
Patent Number
7803909
Abstract
The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
Application Number
11/811,158
Recommended Citation
Yeatman, Timothy J. and Irby, Rosalyn B., "Mutated Src oncogene composition and methods" (2010). USF Patents. 522.
https://digitalcommons.usf.edu/usf_patents/522
Assignees
University of South Florida
Filing Date
06/07/2007
Primary/U.S. Class
530/350
